Edwards Lifesciences makes a simple change for a first-of-its-kind tricuspid valve (opens in new tab)

The first-of-its-kind Edwards Lifesciences Triformis Resilia doesn’t look all that different from the structural heart device developer’s other prosthetic valves, but a simple yet critical design change allows it to address an unmet patient need. Edwards earned FDA approval for Triformis Resilia in May 2026. It’s the first surgical valve designed for the tricuspid position.… The post appeared first on .